Tai: USTR Can Back TRIPS Waiver Talks Without Congressional Approval

By Maria Curi / May 12, 2021 at 6:59 PM
U.S. Trade Representative Katherina Tai on Wednesday defended the Biden administration’s decision to support talks on waiving some World Trade Organization intellectual property protections for COVID-19 vaccines, telling skeptical senators she acted within her authority to take that position without congressional input. Tai last week announced the U.S. would support waiving certain commitments under the WTO’s Agreement on Trade-Related Aspects of Intellectual Property Rights for coronavirus vaccines and “actively participate” in text-based negotiations. The announcement was lauded by civil society...


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.